Terms: = Ovarian cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
9 results:
1. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual treatment Report for 2013.
Nagase S; Ohta T; Takahashi F; Yamagami W; Yaegashi N;
J Obstet Gynaecol Res; 2022 Mar; 48(3):541-552. PubMed ID: 35026864
[TBL] [Abstract] [Full Text] [Related]
2. CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Codilupi T; Taube D; Naegeli H
BMC Cancer; 2019 Nov; 19(1):1042. PubMed ID: 31690264
[TBL] [Abstract] [Full Text] [Related]
3. Hyper IgM Syndrome: a Report from the USIDNET Registry.
Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of ERCC1/xpf genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.
Deloia JA; Bhagwat NR; Darcy KM; Strange M; Tian C; Nuttall K; Krivak TC; Niedernhofer LJ
Gynecol Oncol; 2012 Sep; 126(3):448-54. PubMed ID: 22609620
[TBL] [Abstract] [Full Text] [Related]
5. Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of xpf endonuclease.
Zecevic A; Sampath D; Ewald B; Chen R; Wierda W; Plunkett W
Clin Cancer Res; 2011 Jul; 17(14):4731-41. PubMed ID: 21632856
[TBL] [Abstract] [Full Text] [Related]
6. The significance of duration of chemotherapy interruptions due to interval surgery in ovarian cancer patients treated with neoadjuvant chemotherapy.
Le T; Fathi KA; Hopkins L; Faught W; Fung-Kee-Fung M
J Obstet Gynaecol Can; 2009 Feb; 31(2):161-6. PubMed ID: 19327216
[TBL] [Abstract] [Full Text] [Related]
7. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.
Clingen PH; Wu JY; Miller J; Mistry N; Chin F; Wynne P; Prise KM; Hartley JA
Biochem Pharmacol; 2008 Jul; 76(1):19-27. PubMed ID: 18508035
[TBL] [Abstract] [Full Text] [Related]
8. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
Stevens EV; Nishizuka S; Antony S; Reimers M; Varma S; Young L; Munson PJ; Weinstein JN; Kohn EC; Pommier Y
Mol Cancer Ther; 2008 Jan; 7(1):10-8. PubMed ID: 18187810
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of organ radiation dose associated with uterine artery embolization.
Glomset O; Hellesnes J; Heimland N; Hafsahl G; Smith HJ
Acta Radiol; 2006 Mar; 47(2):179-85. PubMed ID: 16604965
[TBL] [Abstract] [Full Text] [Related]